Literature DB >> 2556841

Interference with vaccinia virus growth caused by insertion of the coding sequence for poliovirus protease 2A.

P C Turner1, D C Young, J B Flanegan, R W Moyer.   

Abstract

Attempts were made to express noninfectious derivatives of full-length type 1 (Mahoney) and type 2 (Lansing) poliovirus cDNAs in live recombinant vaccinia viruses for vaccine purposes. Vaccinia virus (VV) would not tolerate insertions of polio cDNA containing the coding sequence for the polio protease 2A. However, polio cDNA with the 2A gene deleted either in vivo or in vitro could be inserted into VV and stably maintained. Genetic evidence indicated that expression of the polio 2A gene in trans from transfected plasmid DNA was deleterious to vaccinia virus within the same cell. The 2A product presumably interferes with VV growth by modifying the host translational machinery such that translation of host and vaccinia capped mRNAs is inhibited. Polio cDNA containing a mutated 2A gene whose product is no longer active in host protein shutoff could be inserted into VV. However, inserts containing the intact mutated 2A gene did not synthesize detectable poliovirus protein, although they did produce polio-specific RNA. Expression of polio-specific protein was detected from a VV-polio recombinant containing cDNA encoding the capsid proteins plus an incomplete 2A gene. These results have implications regarding possible vaccine construction, and suggest a mechanism for interference between polio and vaccinia viruses in mixed infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556841     DOI: 10.1016/0042-6822(89)90563-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  A stable HeLa cell line that inducibly expresses poliovirus 2A(pro): effects on cellular and viral gene expression.

Authors:  A Barco; E Feduchi; L Carrasco
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  A region of the 5' noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: involvement with the role of L protease in translational control.

Authors:  G J Belsham; J K Brangwyn
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells.

Authors:  P C Turner; M C Sancho; S R Thoennes; A Caputo; R C Bleackley; R W Moyer
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.

Authors:  D C Ansardi; D C Porter; C D Morrow
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Vaccinia virus protein synthesis has a low requirement for the intact translation initiation factor eIF4F, the cap-binding complex, within infected cells.

Authors:  J Mulder; M E Robertson; R A Seamons; G J Belsham
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

6.  Orthopoxvirus fusion inhibitor glycoprotein SPI-3 (open reading frame K2L) contains motifs characteristic of serine proteinase inhibitors that are not required for control of cell fusion.

Authors:  P C Turner; R W Moyer
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.